Form 4: Dexcom Executive Sells Shares
Insider Transaction (Form 4)
Kevin R Sayer, Executive Chair and a Director of Dexcom Inc, sold 26,756 shares of common stock on July 20, 2026 for $76.32 per share.
Summary
- Open-market sale: disposed of 26,756 Common Stock at $76.32 ($2,041,999) on July 20, 2026; holds 328,970 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $2,041,999 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kevin R Sayer — Director, Officer (Executive Chair)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-20 | Open-market sale | Common Stock | 26,756 | $76 | $2.0M | 328,970 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-20 | Open-market sale (26,756 shares) |
Keywords
insider transaction, Form 4, DXCM, DEXCOM INC, bearish, Kevin R Sayer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.